Oral hypoglycemic agents mainly include sulfonylureas, biguanides, α -glucosidase inhibitors, insulin secretion promoters and insulin receptor activators.

Sulfonylureas include thiourea (D860), glibenclamide, Mepida, Dymecon, Coatley and Tang Shiping;

The biguanides include: metformin (Jiangtang tablets, Medekang, Dihua buccal tablets, Gehuazhi, etc. ) and phenformin (Jiangtangling);

α -glucosidase inhibitors are: acarbose;

Insulin secretion promoters are: Novolone;

Insulin receptor activator: Avandia.

It is suggested to choose biguanides, which have a certain effect on body weight.